FDA Inspection 702529 — Sunrise Pharmaceutical, Inc.

Sunrise Pharmaceutical, Inc. — FEI 3004813394

The FDA completed an inspection of Sunrise Pharmaceutical, Inc. on Dec 20, 2010 in Rahway, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 20, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rahway, NJ (United States)

Citations

IDCFRDescription
360321 CFR 211.160(b)Scientifically sound laboratory controls
440121 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.